NEUROCRINE BIOSCIENCES INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Neurocrine Biosciences Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Neurocrine Biosciences Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $6.1M, a 38.6% increase year-over-year.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2023 was $17.9M, a 5.92% increase from 2022.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2022 was $16.9M, a 34.1% increase from 2021.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2021 was $12.6M, a 46.5% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.1M +$1.7M +38.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 $4.4M +$400K +10% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 $4M +$1.4M +53.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $2.6M +$500K +23.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.1M +$500K +31.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $1.6M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.